FRC
FRC Logo
Community
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfileNova Eye Medical Limited
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
EYE.AX
Nova Eye Medical Limited Stock AnalysisComprehensive stock analysis for Nova Eye Medical Limited (EYE.AX) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisEYE.AX
EYE.AX
Nova Eye Medical Limited
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
EYE.AX
  1. Home
  2. Stocks
  3. Nova Eye Medical Limited

Nova Eye Medical Limited

🇦🇺EYE.AX•ASX

Nova Eye Medical Limited

🇦🇺EYE.AX•ASX

Your view on EYE.AX

Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Nova Eye Medical Limited

Industry
Medical - Devices
Sector
Healthcare
CEO
Thomas Spurling
Headquarters
107 Rundle Street, Kent Town, SA, AU
Industry
Medical - Devices
Sector
Healthcare
CEO
Thomas Spurling
Headquarters
107 Rundle Street, Kent Town, SA, AU
Description

Nova Eye Medical Limited specializes in the creation, advancement, distribution, marketing, sale, and servicing of surgical equipment dedicated to treating glaucoma.

Its diverse product line features iTrack, a surgical system engineered to decrease intraocular pressure (IOP) in adult patients with open-angle glaucoma, and iTrack Advance, an innovative system promoting natural ocular fluid drainage.

Furthermore, the company provides Molteno3, a glaucoma drainage device for individuals suffering from severe or intricate forms of the condition, alongside 2RT, a proprietary laser technology employed to address early to intermediate stages of age-related macular degeneration.

With a presence spanning Australia, the United States, Europe, the Asia Pacific, and other international markets, the company, originally established in 1985 as Ellex Medical Lasers Limited, officially became Nova Eye Medical Limited in July 2020. Its corporate headquarters are situated in Kent Town, Australia.

Financial Data

Stock Data

Price chart, volume, and trading data.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

About this section

Valuation, profitability, liquidity and leverage ratios for Nova Eye Medical Limited. Starting points for Nova Eye Medical Limited: EPS -AUD 0.02, beta 0.93 — an Medical - Devices name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

About this section

Dividend history, yield and payout sustainability for Nova Eye Medical Limited. Nova Eye Medical Limited does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

About this section

Reported vs. expected earnings history for Nova Eye Medical Limited. Trailing twelve-month EPS for Nova Eye Medical Limited stands at -AUD 0.02. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Wall Street Analyst Estimates

Analysts' price targets, ratings, and revenue and EPS estimates.

Wall Street analysts· not FRC research
Nov 20, 2026
More →

Earnings per share estimates

Per shareThis quarterSep 2025Next quarterDec 2025This yearYear to Jun 2027Next yearYear to Jun 2028
Average estimateAUD 0.00−AUD 0.01−AUD 0.00AUD 0.01
Lowest estimateAUD 0.00−AUD 0.01−AUD 0.00AUD 0.01
Highest estimateAUD 0.00−AUD 0.01−AUD 0.00AUD 0.01
Number of analysts0111
A year ago−AUD 0.03−AUD 0.01−AUD 0.021—
Growth vs a year ago+100.0%+65.5%——

1The year-ago figure includes one-time items, so growth is not shown.

Revenue estimates

TotalThis quarterSep 2025Next quarterDec 2025This yearYear to Jun 2027Next yearYear to Jun 2028
Average estimateAUD 17.19MAUD 16.40MAUD 42.60MAUD 51.55M
Lowest estimateAUD 17.19MAUD 16.40MAUD 42.38MAUD 51.30M
Highest estimateAUD 17.19MAUD 16.40MAUD 42.82MAUD 51.80M
Number of analysts1122
A year agoAUD 8.63MAUD 13.19MAUD 34.87M—
Growth vs a year ago+99.1%+24.4%+22.2%—

Financial Statements

Income statement, balance sheet, and cash flow statements.

About this section

Income statement, balance sheet and cash flow history for Nova Eye Medical Limited. Nova Eye Medical Limited has reported as a listed company since 1999. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Peers, the industry, and the funds that hold EYE.AX19 companies
Compare EYE.AX with its peers, side by sidePremiumRatios, margins, valuation and leverage of the peers below — one table, one glance.Open Comparable Analysis
Peer companies
TickerTypeCompanySectorIndustry
AGN.AXArgenica Therapeutics LtdHealthcareBiotechnology—
AT1.AXAtomo Diagnostics LimitedHealthcareMedical - Devices—
BDX.AXBCAL Diagnostics LimitedHealthcareMedical - Diagnostics & Research—
EMD.AXEmyria LimitedHealthcareMedical - Healthcare Information Services—
HMD.AXHeraMED LimitedHealthcareMedical - Devices—
IIQ.AXINOVIQ LtdHealthcareMedical - Diagnostics & Research—
LGP.AXLittle Green Pharma LtdHealthcareDrug Manufacturers - Specialty & Generic—
MAP.AXMicroba Life Sciences LimitedHealthcareMedical - Diagnostics & Research—
More Medical - Devices companies
TickerTypeCompanySectorExchangeMkt cap
AMBFFAmbu A/SHealthcareOTC$3.7B
AMIXAutonomix Medical, Inc. Common StockHealthcareNASDAQ$592,199
AORTArtivion, Inc.HealthcareNYSE$904.6M
AQQRFAquarius Surgical Technologies Inc.HealthcareOTC$115,917
ARAYAccuray IncorporatedHealthcareNASDAQ$7.5M
ARMMArmm Inc.HealthcareOTC$106,246
ARX.AXAroa Biosurgery LimitedHealthcareASX—
ASAPFAurora Spine CorporationHealthcareOTC$16.4M
ASG.VAurora Spine CorporationHealthcareTSXV$16.2M
ASTI.CNAquarius Surgical Technologies Inc.HealthcareCNQ—
ATECAlphatec Holdings, Inc.HealthcareNASDAQ$1.1B
Open Comparable Analysis
Ownership & News

News

Latest headlines and market coverage.

About this section

Latest headlines and company announcements for Nova Eye Medical Limited. Coverage tracks Nova Eye Medical Limited within Medical - Devices (Healthcare). Press releases and market coverage, newest first.

Discussion

Comments

Comments and replies from FRC members about this company.

No comments yet

Be the first to ask a question or say what you make of Nova Eye Medical Limited.

EYE.AX AnalysisFair
Past
1
Growth
4
Health
4
Profit
1
Value
1